Our definition of a biomarker is a hypo- or hypermethylated DMR that overlaps a homeobox gene in a single tumor dataset that also passes the set threshold of a difference of 0.2 in the beta values between normal and tumor tissue samples in that statistically significant DMR. This evidence concerns the gene LBX1 and neoplasm.